MOBIDIAG-LTD
Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the expansion of its distribution agreement with PerkinElmer’s Wallac Oy subsidiary to include distribution of the Amplidiag® product line in Israel and several countries in Africa. The Amplidiag® product line, including in vitro diagnostic tests and compatible systems for the detection of gastrointestinal infections, is now distributed in Botswana, Ghana, Ivory Coast, Kenya, Mauritius, Morocco, Mozambique, Nigeria, Rwanda, Senegal, Uganda and Israel.
“Since January 2017 Amplidiag’s product line has been available outside of Europe, and more specifically in South Africa through a distribution agreement with PerkinElmer. The relationship has been very successful since then and as a result we are extending the agreement to speed up our sales coverage in Africa and also to enter the Middle East diagnostics market. We are very pleased that PerkinElmer will continue to support us in our endeavor with its acknowledged expertise and worldwide leadership in the field of diagnostics,” said Tuomas Tenkanen, CEO at Mobidiag.
The agreement is effective immediately and covers all Amplidiag IVD tests (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE and upcoming Amplidiag® Viral GE and Amplidiag® CarbaR+MCR) as well as the Amplidiag® Easy system.
About Amplidiag products
Amplidiag assays are innovative
multiplex tests for the detection of gastrointestinal infections. They
allow screening of panels of the most relevant gastrointestinal
pathogens. Based on well-established real-time PCR technology, they
ensure optimal performance, suitability for high-volume screening use
and cost-effectiveness in mid-sized to large laboratory settings. In
addition, Mobidiag allows process automation from sample extraction to
PCR set-up with the Amplidiag Easy system.
About Mobidiag Ltd
Established in 2000, Mobidiag develops
innovative solutions to advance the diagnosis of infectious diseases and
serves the European clinical diagnostics market since 2008. Mobidiag is
headquartered in Espoo, Finland.
Mobidiag addresses both high to medium volume screening with the new Amplidiag® Easy platform, bringing the Amplidiag suite further by automating the workflow from sample to results, and the upcoming Novodiag® platform & associated panels for a fully automated solution and suitable for smaller volumes and labs. Visit www.mobidiag.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20170529005167/en/
Contact:
Mobidiag Ltd
Tuomas Tenkanen, +358 505534980
tuomas.tenkanen@mobidiag.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AZ-BLUE-YONDER29.3.2024 13:14:28 CET | Press release
Blue Yonder Announces Binding Agreement To Acquire One Network Enterprises for Approximately $839 Million To Create Multi-Enterprise Supply Chain Ecosystem
DEWA29.3.2024 13:13:28 CET | Press release
Dubai Electricity and Water Authority PJSC Shareholders Approve Payment of AED 3.1 Billion in Dividends
LIBERTEX29.3.2024 06:26:33 CET | Press release
PAN Finance Names Libertex ‘Global CFD Broker of the Year’
MIDEA-GROUP29.3.2024 02:40:30 CET | Press release
Midea Group releases its first-ever ESG brand story with an unexpected VIP visit highlighting its commitment to sustainability.
NY-DC-ADMINISTRATION28.3.2024 21:15:26 CET | Press release
DC Secretary Announces Annual Determinations Committees Outcome
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom